Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1436, 2004-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
First-line rituximab good value for NHL in the UK
Inpharma, Vol. 1, Iss. 1572, 2007-01 ,pp. :
By Ray Joshua A. Carr Emma Lewis Gavin Marcus Robert
Value in Health, Vol. 13, Iss. 4, 2010-06 ,pp. :
Bevacizumab: In First-Line Treatment of Metastatic Breast Cancer
Drugs, Vol. 67, Iss. 12, 2007-01 ,pp. :